Obtained $589 Million Settlement in Landmark National Opioid Litigation on Behalf of Tribal Nations
A Historic First in Tribal Government Litigation
In Re: National Prescription Opiate Litigation, 17-cv-2804 (N.D. Ohio)
Robins Kaplan represented 28 Tribal Nations asserting that the manufacturers of prescription opioids grossly misrepresented the risks of long-term use of those drugs for persons with chronic pain, and distributors failed to properly monitor suspicious orders of those prescription drugs, all of which contributed to the current opioid epidemic.
The firm, as part of the Tribal Leadership Committee, secured an initial total settlement of $589 Million on behalf of all federally recognized Tribes.
The firm secured a $439 million settlement of the national opioid litigation claims by Tribes brought against AmerisourceBergen Corp., McKesson Corp., Cardinal Health, Inc. (“Distributors”).
The firm also secured a $150 million settlement of the national opioid litigation claims by Tribes brought against Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc. N/K/A Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., N/K/A Janssen Pharmaceuticals, Inc. (“Janssen”).
This case and these initial settlements represent a historic first in Tribal governments litigating together to exercise their sovereignty.
Holly H. Dolejsi
Deputy Chair, Mass Tort, Personal Injury and Medical Malpractice Groups
Chair, Women of Robins Kaplan Resource Group
Timothy Q. Purdon
Co-Chair, American Indian Law and Policy Group;
Co-Chair, Government and Internal Investigations Group;
Co-Chair, Diversity, Equity and Inclusion Committee
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.